Categories Analysis, Consumer

Estee Lauder (EL): Three factors that do not work in favor of this cosmetics company

For FY2023, net sales are expected to decrease 5-7% on a reported basis

Shares of The Estee Lauder Companies Inc. (NYSE: EL) were down over 1% on Wednesday. The stock has dropped 12% over the past 12 months and 4% year-to-date. The company’s most recent quarter was challenging and it expects headwinds to persist in the near term as well. Here are three factors that do not work in favor of this beauty products maker:

Sales and earnings decline

Estee Lauder saw a decline in both sales and profits for its most recent quarter. Net sales in the second quarter of 2023 fell 17% year-over-year to $4.62 billion on a reported basis while organic net sales dropped 11%. GAAP EPS fell 63% to $1.09 while adjusted EPS was down 49% to $1.54.

The company’s performance during the quarter was impacted by COVID-related headwinds, mainly in China, as well as lower shipments of replenishment orders in the US and the stronger US dollar. However, better-than-expected performance from many developed and emerging markets helped partly offset these challenges.

Category performance

In the second quarter of 2023, Estee Lauder saw reported net sales decline across all its categories except Hair Care, which inched up just 1%. Sales in the Skin Care category fell due to COVID-related headwinds in China and lower replenishment orders in the US. On an organic basis, Skin Care and Makeup saw sales declines while Fragrance and Hair Care posted increases.

The company saw sales decline, both on a reported and organic basis, across all its geographic regions during the quarter. Sales in the Americas declined 3% organically due to lower replenishment orders in the US while sales in Europe, the Middle East & Africa (EMEA) and Asia/Pacific were hurt by COVID-related impacts.

Bleak outlook

Estee Lauder expects its sales to decline both for the third quarter as well as full year of 2023. It also expects certain headwinds to persist thereby delaying its return to growth by another quarter. The company expects net sales for the third quarter of 2023 to decline 12-14% on a reported basis and 8-10% on an organic basis. Adjusted EPS is expected to range between $0.37-0.47, which is below the consensus estimate of $0.51.

For FY2023, net sales are expected to decrease 5-7% on a reported basis while organic net sales are expected to be flat to down 2% versus last year. Adjusted EPS is expected to range between $4.87-5.02.

Estee Lauder lowered its full-year guidance due to higher-than-expected inventory levels in Hainan caused by travel disruptions and in-store staffing levels, as well as near-term pressures related to Korea duty free. This has created greater-than-expected headwinds for the third quarter, offsetting positive impacts from the resumption of international travel by Chinese customers as well as strong performance across several developed and emerging markets globally. As a result of all these factors, the company now expects to return to growth in the fourth quarter instead of the third quarter.

Click here to read the full transcript of Estee Lauder’s Q2 2023 earnings conference call

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top